Vaccine News and Research

Latest Vaccine News and Research

Genomic analysis of the 2022 monkeypox outbreak

In a recent study posted to the bioRxiv* pre-print server, researchers analyzed two genomic sequences of the Monkeypox virus from Belgium and Portugal termed ITM001 and PT0001, respectively, to show that the May 2022 Monkeypox outbreak most likely originated from the West African clade of the virus.

14 Jun 2022

Multi-national scientific task force needed to monitor zoonotic viruses long-term

A new study aimed to identify the main host, intermediate hosts, as well as other animal reservoirs for both SARS-CoV-2 and the monkeypox virus.

13 Jun 2022

Study offers a new and unique treatment for AIDS

A new study from Tel Aviv University offers a new and unique treatment for AIDS which may be developed into a vaccine or a one time treatment for patients with HIV.

13 Jun 2022

Study shows that Omicron infections were associated with a substantially reduced risk of progression to severe clinical outcomes relative to Delta infections

Researchers compared COVID-19 severity outcomes among individuals infected with the SARS-CoV-2 Omicron and Delta variants.

13 Jun 2022

Smartwatches used to monitor short-term effects of 4th BNT162b2 booster shot

In a recent study posted to the medRxiv* pre-print server, researchers in Israel compared the short-term effects of the first and second booster doses of messenger ribonucleic acid (mRNA-based) coronavirus disease 2019 (COVID-19) vaccine BNT162b2.

13 Jun 2022

Study shows safety of COVID-19 vaccines for patients treated for hypothyroidism

Inactivated and mRNA COVID-19 vaccines appear to be safe for patients treated for hypothyroidism, according to a new study being presented at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Ga.

13 Jun 2022

Population-level big data reveals COVID-19 phenotypes

A recent study published in The Lancet Digital Health journal assessed the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection trajectories in England utilizing electronic health records (EHRs).

13 Jun 2022

Commercial T cell test offers insight into immune responses after COVID-19 infection and vaccination

T cell testing using a commercial T cell test, QuantiFERON SARS-CoV-2 RUO, offers insight into the immune response to infection and vaccination of patients with COVID-19 and suggests that age and time from infection are significant factors related to the magnitude of cell-mediated immune (CMI) responses to COVID-19.

13 Jun 2022

SARS-CoV-2 BA.4/5 variants escape vaccine and BA.1 infection induced antibodies

In a recent work published in the Cell journal, investigators examined the severe acute respiratory syndrome coronavirus (SARS-CoV-2) Omicron BA.5/4 variants escape from neutralizing antibodies induced by SARS-CoV-2 vaccines and natural infection.

13 Jun 2022

Animal study suggests intranasal COVID vaccine delivery more efficient than intramuscular

In a recent study published in the journal PNAS, researchers demonstrated higher comparative efficacy of the intranasal (IN) route of coronavirus disease 2019 (COVID-19) vaccine administration versus intramuscular route in mice.

12 Jun 2022

Inhaled vaccines provide better protection and stronger immunity than nasal sprays, study confirms

McMaster University scientists who compared respiratory vaccine-delivery systems have confirmed that inhaled aerosol vaccines provide far better protection and stronger immunity than nasal sprays.

10 Jun 2022

Naturally-produced antibodies in mothers may enhance infants' immunity against bacterial pathogens

Researchers have known for some time that maternal breast milk provides critical nutrients for newborns, and antibodies from mothers vaccinated against a specific disease-causing bacterium or virus can be transferred via breast milk to babies.

10 Jun 2022

Using a harmless amoeba to protect children from dangerous infections

Innovative efforts at the University of Virginia School of Medicine to use a harmless amoeba to protect children from dangerous infections has won critical financial support from The Hartwell Foundation.

10 Jun 2022

Efficacy of BNT162b2 vaccine against SARS-CoV-2 Omicron sublineages and Deltacron

In a recent study posted to the bioRxiv* pre-print server, researchers at the University of Texas Medical Branch, Pfizer Vaccines Research & Development and BioNTech assessed the neutralization titers of sera from individuals vaccinated with the BNT162b2 coronavirus disease 2019 (COVID-19) vaccine and previously infected with the Omicron sublineage BA.1.

10 Jun 2022

Study finds Moderna COVID vaccine efficacy peaks at 94% after 120 days

A recent research letter posted to the JAMA Network Open assessed the durability of immunity conferred by the coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA)-1273 vaccine.

10 Jun 2022

Study reports robust immunity to SARS-CoV-2 including Omicron BA.1 for all three primary vaccines

In a recent study posted to the medRxiv* pre-print server, researchers in the United Kingdom investigated the effect of two Pfizer/BioNTech BNT162b2 vaccine doses or Oxford/AstraZeneca AZ1222 coronavirus disease 2019 (COVID-19) vaccination and a subsequent BNT162b2 booster dose in a cohort of healthcare workers (HCWs) over six to nine months.

10 Jun 2022

COVID-19 vaccination associated with reduction in hospitalizations and mortality among heart failure patients

Heart failure patients who are unvaccinated against SARS-CoV-2, the virus that causes COVID-19, are three times more likely to die if infected with the virus compared to fully boosted heart failure patients, according to new research out of Mount Sinai Heart.

9 Jun 2022

Vaccine News and Research

Latest Vaccine News and Research

Genomic analysis of the 2022 monkeypox outbreak

Multi-national scientific task force needed to monitor zoonotic viruses long-term

Study offers a new and unique treatment for AIDS

Study shows that Omicron infections were associated with a substantially reduced risk of progression to severe clinical outcomes relative to Delta infections

Smartwatches used to monitor short-term effects of 4th BNT162b2 booster shot

Study shows safety of COVID-19 vaccines for patients treated for hypothyroidism

Population-level big data reveals COVID-19 phenotypes

Commercial T cell test offers insight into immune responses after COVID-19 infection and vaccination

SARS-CoV-2 BA.4/5 variants escape vaccine and BA.1 infection induced antibodies

Animal study suggests intranasal COVID vaccine delivery more efficient than intramuscular

Inhaled vaccines provide better protection and stronger immunity than nasal sprays, study confirms

Naturally-produced antibodies in mothers may enhance infants' immunity against bacterial pathogens

Using a harmless amoeba to protect children from dangerous infections

Efficacy of BNT162b2 vaccine against SARS-CoV-2 Omicron sublineages and Deltacron

Study finds Moderna COVID vaccine efficacy peaks at 94% after 120 days

Study reports robust immunity to SARS-CoV-2 including Omicron BA.1 for all three primary vaccines

COVID-19 vaccination associated with reduction in hospitalizations and mortality among heart failure patients

KHN’s ‘What the Health?’: Taking a shot at gun control

New understanding about malaria immunity could lead to the development of effective vaccines

Insights on the T cell epitope landscape for the five main SARS-CoV-2 variants of concern

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in